{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T18:11:32Z","timestamp":1789668692893,"version":"4.0.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T00:00:00Z","timestamp":1784505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T00:00:00Z","timestamp":1784505600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1245\/s10434-026-20060-1","type":"journal-article","created":{"date-parts":[[2026,7,19]],"date-time":"2026-07-19T22:20:59Z","timestamp":1784499659000},"page":"8993-9001","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Treatment for Oligo-recurrence of Diffuse Pleural Mesothelioma After Extended Pleurectomy\/Decortication"],"prefix":"10.1245","volume":"33","author":[{"given":"Ryo","family":"Wakejima","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hironori","family":"Ishibashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayaka","family":"Asakawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuya","family":"Ishikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Sugita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenichi","family":"Okubo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,20]]},"reference":[{"key":"20060_CR1","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1200\/JCO.2008.19.8523","volume":"27","author":"AS Tsao","year":"2009","unstructured":"Tsao AS, Wistuba I, Roth JA, Kindler HL. Malignant pleural mesothelioma. J Clin Oncol. 2009;27:2081\u201390.","journal-title":"J Clin Oncol"},{"key":"20060_CR2","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1097\/JTO.0b013e31826915f1","volume":"7","author":"VW Rusch","year":"2012","unstructured":"Rusch VW, Giroux D, Kennedy C, et al. Initial analysis of the International Association for the Study of Lung Cancer Mesothelioma Database. J Thorac Oncol. 2012;7:1631\u20139.","journal-title":"J Thorac Oncol"},{"key":"20060_CR3","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1097\/01243894-200602000-00014","volume":"1","author":"DJ Sugarbaker","year":"2006","unstructured":"Sugarbaker DJ. Macroscopic complete resection: the goal of primary surgery in multimodality therapy for pleural mesothelioma. J Thorac Oncol. 2006;1:175\u20136.","journal-title":"J Thorac Oncol"},{"key":"20060_CR4","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1016\/j.jtcvs.2013.01.039","volume":"145","author":"V Rusch","year":"2013","unstructured":"Rusch V, Baldini EH, Bueno R, et al. The role of surgical cytoreduction in the treatment of malignant pleural mesothelioma: meeting summary of the International Mesothelioma Interest Group Congress, September 11\u201314, 2012, Boston. Mass J Thorac Cardiovasc Surg. 2013;145:909\u201310.","journal-title":"Mass. J Thorac Cardiovasc Surg"},{"key":"20060_CR5","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1200\/JCO.2017.76.6394","volume":"36","author":"HL Kindler","year":"2018","unstructured":"Kindler HL, Ismaila N, Armato SG 3rd, et al. Treatment of malignant pleural mesothelioma: American Society of Clinical Oncology Clinical Practice Guideline. J Clin Oncol. 2018;36:1343\u201373.","journal-title":"J Clin Oncol"},{"key":"20060_CR6","doi-asserted-by":"publisher","first-page":"1900953","DOI":"10.1183\/13993003.00953-2019","volume":"55","author":"A Scherpereel","year":"2020","unstructured":"Scherpereel A, Opitz I, Berghmans T, et al. ERS\/ESTS\/EACTS\/ESTRO guidelines for the management of malignant pleural mesothelioma. Eur Respiratory J. 2020;55:1900953.","journal-title":"Eur Respiratory J"},{"key":"20060_CR7","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1016\/S1470-2045(21)00471-X","volume":"22","author":"DA Fennell","year":"2021","unstructured":"Fennell DA, Ewings S, Ottensmeier C, et al. Nivolumab versus placebo in patients with relapsed malignant mesothelioma (CONFIRM): a multicentre, double-blind, randomised, phase 3 trial. Lancet Oncol. 2021;22:1530\u201340.","journal-title":"Lancet Oncol"},{"key":"20060_CR8","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/S0140-6736(20)32714-8","volume":"397","author":"P Baas","year":"2021","unstructured":"Baas P, Scherpereel A, Nowak AK, et al. First-line nivolumab plus ipilimumab in unresectable malignant pleural mesothelioma (CheckMate 743): a multicentre, randomised, open-label, phase 3 trial. Lancet. 2021;397:375\u201386.","journal-title":"Lancet"},{"key":"20060_CR9","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1097\/JTO.0b013e31827740f0","volume":"8","author":"DR Gomez","year":"2013","unstructured":"Gomez DR, Hong DS, Allen PK, et al. Patterns of failure, toxicity, and survival after extrapleural pneumonectomy and hemithoracic intensity-modulated radiation therapy for malignant pleural mesothelioma. J Thorac Oncol. 2013;8:238\u201345.","journal-title":"J Thorac Oncol"},{"key":"20060_CR10","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1093\/ejcts\/ezv398","volume":"49","author":"A Kostron","year":"2016","unstructured":"Kostron A, Friess M, Crameri O, et al. Relapse pattern and second-line treatment following multimodality treatment for malignant pleural mesothelioma. Eur J Cardio-Thorac Surg. 2016;49:1516\u201323.","journal-title":"Eur J Cardio-Thorac Surg"},{"key":"20060_CR11","doi-asserted-by":"crossref","unstructured":"Kai Y, Tsutani Y, Tsubokawa N, et al. Prolonged post\u2011recurrence survival following pleurectomy\/decortication for malignant pleural mesothelioma. Oncol Lett. 2019;17:3607\u201314.","DOI":"10.3892\/ol.2019.9979"},{"key":"20060_CR12","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.3390\/jcm10051134","volume":"10","author":"A Bellini","year":"2021","unstructured":"Bellini A, Dell\u2019Amore A, Terzi S, et al. Relapse patterns and tailored treatment strategies for malignant pleural mesothelioma recurrence after multimodality therapy. J Clin Med. 2021;10:1134.","journal-title":"J Clin Med"},{"key":"20060_CR13","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1016\/j.athoracsur.2019.11.048","volume":"109","author":"A Nakamura","year":"2020","unstructured":"Nakamura A, Takuwa T, Hashimoto M, et al. Clinical outcomes with recurrence after pleurectomy\/decortication for malignant pleural mesothelioma. Ann Thorac Surg. 2020;109:1537\u201343.","journal-title":"Ann Thorac Surg"},{"key":"20060_CR14","doi-asserted-by":"publisher","first-page":"2112","DOI":"10.1016\/j.jtho.2016.09.124","volume":"11","author":"VW Rusch","year":"2016","unstructured":"Rusch VW, Chansky K, Kindler HL, et al. The IASLC Mesothelioma staging project: proposals for the M descriptors and for revision of the TNM stage groupings in the forthcoming (eighth) edition of the TNM Classification for Mesothelioma. J Thorac Oncol. 2016;11:2112\u20139.","journal-title":"J Thorac Oncol"},{"key":"20060_CR15","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1016\/j.xjon.2023.09.005","volume":"16","author":"K Okubo","year":"2023","unstructured":"Okubo K, Ishibashi H, Wakejima R, Baba S, Asakawa A, Seshima H. Extended pleurectomy\/decortication and hyperthermic intraoperative intrapleural cisplatin perfusion for malignant pleural mesothelioma. JTCVS Open. 2023;16:977\u201386.","journal-title":"JTCVS Open"},{"key":"20060_CR16","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1016\/j.jtcvs.2012.12.037","volume":"145","author":"DJ Sugarbaker","year":"2013","unstructured":"Sugarbaker DJ, Gill RR, Yeap BY, et al. Hyperthermic intraoperative pleural cisplatin chemotherapy extends interval to recurrence and survival among low-risk patients with malignant pleural mesothelioma undergoing surgical macroscopic complete resection. J Thorac Cardiovasc Surg. 2013;145:955\u201363.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"20060_CR17","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/261096","volume":"2012","author":"Y Niibe","year":"2012","unstructured":"Niibe Y, Chang JY. Novel insights of oligometastases and oligo-recurrence and review of the literature. Pulm Med. 2012;2012:261096.","journal-title":"Pulm Med"},{"key":"20060_CR18","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.athoracsur.2021.04.078","volume":"113","author":"N Zhou","year":"2022","unstructured":"Zhou N, Rice DC, Tsao AS, et al. Extrapleural pneumonectomy versus pleurectomy\/decortication for malignant pleural mesothelioma. Ann Thorac Surg. 2022;113:200\u20138.","journal-title":"Ann Thorac Surg"},{"key":"20060_CR19","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1093\/ejcts\/ezv403","volume":"49","author":"AJ Sharkey","year":"2016","unstructured":"Sharkey AJ, Tenconi S, Nakas A, Waller DA. The effects of an intentional transition from extrapleural pneumonectomy to extended pleurectomy\/decortication. Eur J Cardiothorac Surg. 2016;49:1632\u201341.","journal-title":"Eur J Cardiothorac Surg"},{"key":"20060_CR20","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1177\/0218492312454017","volume":"21","author":"T Ploenes","year":"2013","unstructured":"Ploenes T, Osei-Agyemang T, Krohn A, et al. Changes in lung function after surgery for mesothelioma. Asian Cardiovasc Thorac Ann. 2013;21:48\u201355.","journal-title":"Asian Cardiovasc Thorac Ann"},{"key":"20060_CR21","doi-asserted-by":"crossref","unstructured":"Schwartz RM, Lieberman-Cribbin W, Wolf A, Flores RM, Taioli E. Systematic review of quality of life following pleurectomy decortication and extrapleural pneumonectomy for malignant pleural mesothelioma. BMC Cancer. 2018;18:1188.","DOI":"10.1186\/s12885-018-5064-4"},{"key":"20060_CR22","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1097\/JTO.0b013e31824de2dc","volume":"7","author":"S B\u00f6l\u00fckbas","year":"2012","unstructured":"B\u00f6l\u00fckbas S, Eberlein M, Schirren J. Prospective study on functional results after lung-sparing radical pleurectomy in the management of malignant pleural mesothelioma. J Thorac Oncol. 2012;7:900\u20135.","journal-title":"J Thorac Oncol"},{"key":"20060_CR23","doi-asserted-by":"crossref","unstructured":"Burt BM, Ali SO, DaSilva MC, et al. Clinical indications and results after chest wall resection for recurrent mesothelioma. J Thorac Cardiovasc Surg. 2013;146:1373-9; discussion 9-80.","DOI":"10.1016\/j.jtcvs.2013.07.012"},{"key":"20060_CR24","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.athoracsur.2009.09.028","volume":"89","author":"L Politi","year":"2010","unstructured":"Politi L, Borzellino G. Second surgery for recurrence of malignant pleural mesothelioma after extrapleural pneumonectomy. Ann Thorac Surg. 2010;89:207\u201310.","journal-title":"Ann Thorac Surg"},{"key":"20060_CR25","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.athoracsur.2006.08.046","volume":"83","author":"H Sugimura","year":"2007","unstructured":"Sugimura H, Nichols FC, Yang P, et al. Survival after recurrent nonsmall-cell lung cancer after complete pulmonary resection. Ann Thorac Surg. 2007;83:409\u201318.","journal-title":"Ann Thorac Surg"},{"key":"20060_CR26","doi-asserted-by":"publisher","first-page":"7912","DOI":"10.1245\/s10434-021-10062-6","volume":"28","author":"TL Sutton","year":"2021","unstructured":"Sutton TL, Walker BS, Billingsley KG, et al. Disease-free interval is associated with oncologic outcomes in patients with recurrent gastrointestinal stromal tumor. Ann Surg Oncol. 2021;28:7912\u201320.","journal-title":"Ann Surg Oncol"},{"key":"20060_CR27","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1093\/ejcts\/ezv249","volume":"49","author":"T Hishida","year":"2016","unstructured":"Hishida T, Yoshida J, Aokage K, Nagai K, Tsuboi M. Postoperative oligo-recurrence of non-small-cell lung cancer: clinical features and survival. Eur J Cardio-Thorac Surg. 2016;49:847\u201353.","journal-title":"Eur J Cardio-Thorac Surg"}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-026-20060-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-026-20060-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-026-20060-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T17:53:09Z","timestamp":1789667589000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-026-20060-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,20]]},"references-count":27,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["20060"],"URL":"https:\/\/doi.org\/10.1245\/s10434-026-20060-1","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,20]]},"assertion":[{"value":"26 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors have no conflicts of interest directly relevant to the content of this article.","order":1,"name":"Ethics","label":"Disclosure","group":{"name":"EthicsHeading","label":"Ethics"}}]}}